SION – sionna therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Sionna Therapeutics, Inc. (NASDAQ: SION) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Sionna Therapeutics, Inc. (NASDAQ: SION) is now covered by analysts at Guggenheim. They set a "buy" rating and a $45.00 price target on the stock.
Sionna Therapeutics, Inc. (NASDAQ: SION) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $32.00 price target on the stock.
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
Form 3 Sionna Therapeutics, For: Apr 01 Filed by: Fitzpatrick Jennifer
Form 10-K Sionna Therapeutics, For: Dec 31
Form 8-K Sionna Therapeutics, For: Mar 20
Form SEC STAFF LETTER Sionna Therapeutics,
Form SEC STAFF LETTER Sionna Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.